Stay updated on Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Expanded the page's Locations section to list trial sites by state (California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois, Kansas, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, New Hampshire, New York, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Vermont) and added the Revision: v3.3.3 tag; removed individual state 'Locations' blocks and the HHS Vulnerability Disclosure link.
    Difference
    1.0%
    Check dated 2025-12-23T00:50:54.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.3.2 updated; no substantive changes to study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:22:45.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Publication section description updated to indicate automatic PubMed population; Revision: v3.3.1 replaces v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-24T11:55:58.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Removed the temporary government funding notice regarding NIH operations from the page. This change does not modify the study data, eligibility criteria, or links on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-17T06:16:10.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    No significant changes to core study information, eligibility criteria, primary/secondary outcomes, or location lists; the page content appears unchanged beyond non-substantive UI differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T00:50:27.000Z thumbnail image
  9. Check
    89 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed.
    Difference
    2%
    Check dated 2025-10-05T07:43:39.000Z thumbnail image

Stay in the know with updates to Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib vs Chemotherapy in BRCA+ Metastatic Breast Cancer Clinical Trial page.